Results 201 to 210 of about 694,423 (327)

L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.

open access: yesCochrane Database of Systematic Reviews, 2018
E. T. Goh   +5 more
semanticscholar   +1 more source

Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 5, September 2025.
ABSTRACT Pyridox(am)ine 5′‐phosphate oxidase (PNPO) deficiency is an ultrarare inherited neurometabolic disease, characterized by primarily neonatal‐onset B6‐responsive epileptic encephalopathies. Treatment often requires sustainable access to high‐quality pyridoxal‐5′‐phosphate (PLP, i.e., active vitamin B6), although some patients (also) respond to ...
Nina N. Stolwijk   +7 more
wiley   +1 more source

Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024). [PDF]

open access: yesJ Clin Transl Hepatol
Xu X   +13 more
europepmc   +1 more source

Treatment of Inborn Errors by Product Replacement: The Example of Inborn Errors of Bile Acid Synthesis

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 5, September 2025.
ABSTRACT Many inborn errors of metabolism affect pathways involved in the synthesis of a metabolite that has an important biochemical or physiological function, and adverse effects of the disorder can be attributed to the lack of this metabolite. Thus, there is the opportunity for treatment by ‘product replacement’. One of the disorders in the pathways
Peter T. Clayton   +2 more
wiley   +1 more source

Hepatic encephalopathy - therapy [PDF]

open access: bronze, 2003
M Wettstein, Dieter Häussinger
openalex   +1 more source

Consciousness disturbance due to lithium carbonate intoxication developed in a patient with cancer and bipolar affective disorder: A case report and literature review

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 4, Issue 3, September 2025.
Abstract Background Patients with comorbid cancer and bipolar affective disorder require psychiatric symptom stabilization to continue cancer treatment, and mood stabilizers, including lithium carbonate, are often administered during cancer treatment.
Junji Yamaguchi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy